nci logo
NIH
U.S. National Institutes of Health National Cancer Institute

SEER Inquiry System - Home


Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.
Recent Questions << First    < Prev 10    1110 to 1119 of 1119   
Add to Report ID Question Status Last Updated
20000258 EOD-Extension--Lung: If a CT scan indicates that a patient has evidence of "long-standing pneumonia," is that considered synonymous with "pneumonitis" for the purposes of coding extension for lung primaries? Final Feb 21 2005
20000256 EOD-Size of Primary Tumor--Melanoma: How do you code tumor size for a melanoma diagnosed by a positive lymph node biopsy when the primary site is coded C44.9 because no primary site was identified? Final Feb 21 2005
20000249 EOD-Lymph Nodes--Melanoma: Should we assume that positive lymph nodes are to be considered regional if the primary site for a melanoma is not identified (i.e., C44.9)? Final Feb 21 2005
20000248 Date of Diagnosis: When doing follow-back at nursing homes on DCO cases, we find it difficult to code diagnosis date because the nursing home records are often vague or incomplete. Should the diagnosis date be coded as unknown (excluded from SEER database), the date of death, or the approximate date of diagnosis as reported on the death certificate? Final Apr 29 2003
20000247 EOD-Pathologic Extension--Prostate: If there is residual tumor in the distal urethra on prostatectomy, does that mean there is distal urethral margin involvement? Please see example under "Discussion." Final Oct 05 2005
20000246 Grade, Differentiation--All Sites: If a patient had pre-surgical neoadjuvant treatment, can you code the grade of tumor from the subsequent pathology report? Final Feb 20 2005
20000245 Reportability/In situ: Are the terms "high grade dysplasia" and "severe dysplasia" synonymous with in situ? Final Feb 20 2005
20000244 Behavior Code--Bladder/Lymphoma: Should the "in situ" designation on a bladder primary's pathology report be ignored that states a diagnosis of "in situ lymphoma"? Final Mar 05 2008
20000243 Surgery of Primary Site--Lung: What code is used to represent "photodynamic therapy" (PDT) for lung primaries? Final Feb 19 2005
20000242 EOD-Size of Primary Tumor--Prostate: Should the size of tumor be recorded as 001 (focus) or the actual size when both are stated? Final Sep 02 2008
< Prev 10